E MacIntyre
Overview
Explore the profile of E MacIntyre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
3223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
MacIntyre E, Braithwaite F, Stanton T, Burke A
J Pain
. 2023 Dec;
25(6):104446.
PMID: 38101527
This study provides an update on multidisciplinary staffing and clinical activity in Australian specialist persistent pain services. Of the 109 services identified, 57 responded, met inclusion criteria and completed a...
2.
Kiesewetter B, Dafni U, de Vries E, Barriuso J, Curigliano G, Gonzalez-Calle V, et al.
Ann Oncol
. 2023 Jun;
34(9):734-771.
PMID: 37343663
Background: The European Society for Medical Oncology (ESMO)-Magnitude of Clinical Benefit Scale (MCBS) has been accepted as a robust tool to evaluate the magnitude of clinical benefit reported in trials...
3.
Braithwaite F, Arnold J, Davis A, Gwilt I, MacIntyre E, Morris S, et al.
Osteoarthritis Cartilage
. 2023 Mar;
31(7):944-953.
PMID: 36924920
Introduction: Co-design is a consumer-driven approach that facilitates consumer participation in creating meaningful solutions to complex problems. Poor uptake of core management strategies for osteoarthritis suggests there is a missing...
4.
Rouzaud C, Vercellino L, De Kerviler E, Raffoux E, Balsat M, Marcais A, et al.
Br J Haematol
. 2023 Mar;
201(3):e21-e24.
PMID: 36890721
No abstract available.
5.
Magnani A, Semeraro M, Adam F, Booth C, Dupre L, Morris E, et al.
Nat Med
. 2022 Aug;
28(10):2217.
PMID: 35945284
No abstract available.
6.
Magnani A, Semeraro M, Adam F, Booth C, Dupre L, Morris E, et al.
Nat Med
. 2022 Jan;
28(1):71-80.
PMID: 35075289
Patients with Wiskott-Aldrich syndrome (WAS) lacking a human leukocyte antigen-matched donor may benefit from gene therapy through the provision of gene-corrected, autologous hematopoietic stem/progenitor cells. Here, we present comprehensive, long-term...
7.
Seitz V, Kleo K, Droge A, Schaper S, Elezkurtaj S, Bedjaoui N, et al.
Sci Rep
. 2020 Jun;
10(1):10024.
PMID: 32572036
T-cell receptor gene beta (TCRβ) gene rearrangement represents a complex, tightly regulated molecular mechanism involving excision, deletion and recombination of DNA during T-cell development. RUNX1, a well-known transcription factor for...
8.
Villarese P, Lours C, Trinquand A, Le Noir S, Belhocine M, Lhermitte L, et al.
Leukemia
. 2017 Jun;
32(1):61-71.
PMID: 28592888
T-cell acute lymphoblastic leukemia (T-ALL) results from leukemic transformation of T-cell precursors arrested at specific differentiation stages, including an 'early-cortical' thymic maturation arrest characterized by expression of cytoplasmic TCRβ but...
9.
Tesio M, Trinquand A, Ballerini P, Hypolite G, Lhermitte L, Petit A, et al.
Leukemia
. 2017 May;
31(12):2594-2600.
PMID: 28539671
The tumour suppressor gene PTEN is commonly altered in T-cell acute lymphoblastic leukaemia but its prognostic impact is still debated. We screened a cohort of 573 fully characterised adult and...
10.
Cordonnier G, Mandoli A, Radhouane A, Hypolite G, Lhermitte L, Belhocine M, et al.
Leukemia
. 2017 Feb;
31(6):1443-1446.
PMID: 28196984
No abstract available.